Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics.
The report details the trend, potential and market size of Bipolar Disorder Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bipolar Disorder Drugsmarket, defines the market attractiveness level of Bipolar Disorder Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bipolar Disorder Drugs industry, describes the types of Bipolar Disorder Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bipolar Disorder Drugs market and the development prospects and opportunities of Bipolar Disorder Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bipolar Disorder Drugs market in Chapter 13.
By Player:
Novartis
GlaxoSmithKline
AstraZeneca
AbbVie
Allergan
Bristol-Myers Squibb Company
Astellas Pharma
Eli Lilly
Pfizer
By Type:
Mood Stabilizers
Antipsychotic Drugs
Antidepressant Drugs
Other Drugs
By End-User:
Hospital
Lab
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bipolar Disorder Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bipolar Disorder Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bipolar Disorder Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bipolar Disorder Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bipolar Disorder Drugs Market Analysis and Outlook to 2022
-
7.1 Global Bipolar Disorder Drugs Consumption (2017-2022)
-
7.2 United States Bipolar Disorder Drugs Consumption (2017-2022)
-
7.3 Europe Bipolar Disorder Drugs Consumption (2017-2022)
-
7.4 China Bipolar Disorder Drugs Consumption (2017-2022)
-
7.5 Japan Bipolar Disorder Drugs Consumption (2017-2022)
-
7.6 India Bipolar Disorder Drugs Consumption (2017-2022)
-
7.7 South Korea Bipolar Disorder Drugs Consumption (2017-2022)
8 Region and Country-wise Bipolar Disorder Drugs Market Analysis and Outlook to 2028
-
8.1 Global Bipolar Disorder Drugs Consumption Forecast (2022-2028)
-
8.2 United States Bipolar Disorder Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Bipolar Disorder Drugs Consumption Forecast (2022-2028)
-
8.4 China Bipolar Disorder Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Bipolar Disorder Drugs Consumption Forecast (2022-2028)
-
8.6 India Bipolar Disorder Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Bipolar Disorder Drugs Consumption Forecast (2022-2028)
9 Global Bipolar Disorder Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Bipolar Disorder Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Mood Stabilizers Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antipsychotic Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Antidepressant Drugs Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Bipolar Disorder Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Lab Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Bipolar Disorder Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Bipolar Disorder Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Mood Stabilizers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antipsychotic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Antidepressant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bipolar Disorder Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Lab Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Bipolar Disorder Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bipolar Disorder Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bipolar Disorder Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bipolar Disorder Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bipolar Disorder Drugs Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Bipolar Disorder Drugs Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Bipolar Disorder Drugs Product and Service
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Details
-
14.3.2 AstraZeneca Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca Bipolar Disorder Drugs Product and Service
-
14.4 AbbVie
-
14.4.1 AbbVie Company Details
-
14.4.2 AbbVie Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AbbVie Bipolar Disorder Drugs Product and Service
-
14.5 Allergan
-
14.5.1 Allergan Company Details
-
14.5.2 Allergan Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Allergan Bipolar Disorder Drugs Product and Service
-
14.6 Bristol-Myers Squibb Company
-
14.6.1 Bristol-Myers Squibb Company Company Details
-
14.6.2 Bristol-Myers Squibb Company Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bristol-Myers Squibb Company Bipolar Disorder Drugs Product and Service
-
14.7 Astellas Pharma
-
14.7.1 Astellas Pharma Company Details
-
14.7.2 Astellas Pharma Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Astellas Pharma Bipolar Disorder Drugs Product and Service
-
14.8 Eli Lilly
-
14.8.1 Eli Lilly Company Details
-
14.8.2 Eli Lilly Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eli Lilly Bipolar Disorder Drugs Product and Service
-
14.9 Pfizer
-
14.9.1 Pfizer Company Details
-
14.9.2 Pfizer Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Pfizer Bipolar Disorder Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bipolar Disorder Drugs
-
Figure Bipolar Disorder Drugs Picture
-
Table Global Bipolar Disorder Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bipolar Disorder Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bipolar Disorder Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bipolar Disorder Drugs Consumption by Country (2017-2022)
-
Figure United States Bipolar Disorder Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Bipolar Disorder Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Bipolar Disorder Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Bipolar Disorder Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Bipolar Disorder Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bipolar Disorder Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Bipolar Disorder Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Bipolar Disorder Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bipolar Disorder Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bipolar Disorder Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bipolar Disorder Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bipolar Disorder Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bipolar Disorder Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mood Stabilizers Consumption and Growth Rate (2017-2022)
-
Figure Global Antipsychotic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Antidepressant Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Other Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Lab Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Mood Stabilizers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antipsychotic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antidepressant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bipolar Disorder Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bipolar Disorder Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Bipolar Disorder Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Bipolar Disorder Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Bipolar Disorder Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Bipolar Disorder Drugs Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Bipolar Disorder Drugs Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Bipolar Disorder Drugs Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Bipolar Disorder Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Bipolar Disorder Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Bipolar Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Bipolar Disorder Drugs Product and Service
-
